The U.S. Food and Drug Administration (FDA) has expanded approval for a personalized cellular therapy developed at the University of Pennsylvania’s Abramson Cancer Center, this time for the treatment of adult patients with relapsed or refractory large B-Cell lymphoma after two or more lines of systemic therapy.

We’re excited to kick off National ALS Awareness Month.

Among more than 230,000 cardiac patients who had sustained a heart attack or undergone one of two common heart procedures, only 16 percent participated in a formal exercise program after their hospitalization – despite the program’s demonstrated benefits to health.

Two studies examine whether exposure to chemicals from the wreckage of the World Trade Center during rescue and recovery work after the September 11, 2001 attacks increased firefighters’ risk of developing cancer.

Every 40 seconds someone in the U.S. has a stroke, and every four minutes, someone dies from a stroke, according to the U.S. Centers for Disease Control and Prevention (CDC).

The American Cancer Society Cancer Action Network (ACS CAN), gave testimony today to express their concerns about legislation that has been passed by the Michigan Senate and is being considered by the House Appropriations Committee.

The Biotechnology Innovation Organization (BIO) and BioForward Wisconsin commend Governor Scott Walker for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physicians.

An HIV treatment regimen already widely used in North America and Europe would likely increase the life expectancy of people living with HIV in India by nearly three years and reduce the number of new HIV infections by 23 percent with minimal impact on the country’s HIV/AIDS budget.

In an effort to unite communities and families to raise money for pediatric cancer research, Cleveland Clinic has launched VeloSano Kids, a year-round community fundraising initiative.

Eli Lilly and Company (NYSE: LLY) and Indiana University's Richard M. Fairbanks School of Public Health at IUPUI announced today the launch of a new neighborhood-based, data-driven pilot in Indianapolis to help address the high incidence of diabetes.

A recent study led by UCLA researchers found that lupus is among the leading causes of death in young women.

When a new park is built, a tax is instituted on fast food or a ban put in place against soft drinks in a school, public health researchers must often rely on “after the fact” observational studies to evaluate the impact of such efforts on rates of obesity in a particular population and try to clearly identify and measure the factors that worked or didn’t.

Sanofi (NYSE: SNY; EURONEXT: SAN) and Regeneron Pharmaceuticals, Inc. today announced they will lower the net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access from Express Scripts.

As their name implies, awareness of rare cancers is lower compared to cancers that are more common. In turn, research funding to improve patient outcomes with rare cancers is also lower.

Due to the opioid epidemic, hepatitis C virus (HCV) is increasing among pregnant women, resulting in a greater risk of perinatal transmission and HCV infection among children.

To continue providing ongoing support to new parents, UPMC has expanded its partnership with NurturePA, Inc. – a mentoring program that uses text messaging – to include both UPMC Mercy hospital and UPMC Magee-Womens Hospital.

Detecting and monitoring cancer through imaging has made great strides over the decades in an effort to reduce invasive biopsies or surgeries.

Bon Secours Health System, VCU Health and Virginia Premier announced today they have formed a new partnership to bring more options in 2019 to patients insured on the Affordable Care Act health insurance exchange in Central Virginia.

Anxiety has already been shown to take its toll on the human body in many ways, including increased risk for heart disease and gastrointestinal disorders.

A new kind of magnetic resonance imaging (MRI) component in the shape of a glove delivers the first clear images of bones, tendons, and ligaments moving together, a new study finds.